IOVA Iovance Biotherapeutics Inc

Lion Biotechnologies Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.

$30.17  -1.14 (-3.64%)
As of 04/09/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/26/2010
Outstanding shares:  146,979,253
Average volume:  2,576,656
Market cap:   $4,437,303,648
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    462260100
ISIN:        US4622601007
Sedol:      BF0DMK7
Valuation   (See tab for details)
PE ratio:   -75.76
PB ratio:   6.75
PS ratio:   0.00
Return on equity:   -39.54%
Net income %:   -1,297,905,000,000.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy